References
- DubeyJPToxoplasmosis of Animals and Humans2nd edNew YorkBoca Raton20101313
- TenterAMHeckerothARWeissLMToxoplasma gondii: from animals to humansInt J Parasitol2000301217125811113252
- TuazonCUToxoplasmosis in AIDS patientsJ Antimicrob Chemother19892377822654118
- RostamiAKeshavarzHShojaeeSMohebaliMMeamarARFrequency of Toxoplasma gondii in HIV positive patients from west of Iran by ELISA and PCRIran J Parasitol2014947448125759728
- SharbatkhoriMMoghaddamYDPaghehASMohammadiRMofidiHHShojaeeSSeroprevalence of Toxoplasma gondii infections in pregnant women in Gorgan City, Golestan Province, Northern IranIran J Parasitol2014918118725848383
- Martins-DuarteESUrbinaJASouzaWVommaroRCAntiprolif-erative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitroJ Antimicrob Chemother200658596516702175
- KhanIKhanMUmarMNOhDHNanobiotechnology and its applications in drug delivery system: a reviewIET Nanobiotechnol2015939640026647817
- HosseinnejadMJafariSMKatouzianIInorganic and metal nanoparticles and their antimicrobial activity in food packaging applicationsCrit Rev Microbiol2017121
- AngeliEBuzioRFirpoGNanotechnology applications in medicineTumori20089420621518564609
- DebbagePTargeted drugs and nanomedicine: present and futureCurr Pharm Des20091515317219149610
- KeanTThanouMBiodegradation, biodistribution and toxicity of chitosanAdv Drug Deliv Rev20096231119800377
- GoyRCDe BrittoDAssisOBGA review of the antimicrobial activity of chitosanPolimeros200919241247
- De MarchiJGJornadaDSSilvaFKTriclosan resistance reversion by encapsulation in chitosan-coated-nanocapsule containing α-bisabolol as core: development of wound dressingInt J Nanomedicine2017127855786829123398
- WangJJZengZWXiaoRZRecent advances of chitosan nanoparticles as drug carriersInt J Nanomedicine2011676577421589644
- HosseinnejadMJafariSMEvaluation of different factors affecting antimicrobial properties of chitosanInt J Biol Macromol20168546747526780706
- JeonYJParkPJKimSKAntimicrobial effect of chitooligosaccharides produced by bioreactorCarbohydr Polym2001447176
- JeonYJKimSKProduction of chitooligosaccharides using an ultra-filtration membrane reactor and their antibacterial activityCarbohydr Polym200041133144
- NoHKParkNYLeeSHMeyersSPAntibacterial activity of chitosans and chitosan oligomers with different molecular weightsInt J Food Microbiol200274657211929171
- UenoKYamaguchiTSakairiNNishiNTokuraSAntimicrobial activity by fractionated chitosan oligomersDomardARobertsGAFVarumKMAdvances in Chitin Science (II)Lyon, FranceJacques Andre1997156161
- Ali-HeydariSKeshavarzHShojaeeSMohebaliMDiagnosis of antigenic markers of acute toxoplasmosis by IgG avidity immunoblottingParasite201320201823707895
- JiangTDChitosanBeijing, ChinaChemical Industry Press200191100108
- LewandowskaKViscometric studies in dilute solution mixtures of chitosan and microcrystalline chitosan with poly(vinyl alcohol)J Solution Chem2013421654166224039317
- KoukarasENPapadimitriouSABikiarisDNFroudakisGEInsight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphateMol Pharm201292856286222845012
- DzitkoKPanethAPlechT1, 4-disubstituted thiosemicarbazide derivatives are potent inhibitors of Toxoplasma gondii proliferationMolecules2014199926994325010466
- BurgJLGroverCMPoulettyPBoothroydJCDirect and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reactionJ Clin Microbiol198927178717922768467
- JeroenPJSaeijJPBoyleMEGriggGABoothroydJCBio-luminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strainsInfect Immun20057369570215664907
- FletcherRHFletcherSWWagnerEHClinical Epidemiology: The Essentials3rd edBaltimoreWilliams and Wilkins1996
- ShubarHMLachenmaierSHeimesaatMMSDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriersJ Drug Target20111911412420367080
- CowanMMPlant products as antimicrobial agentsClin Microbiol Rev19991256458210515903
- VerleeAMinckeSStevensCVRecent developments in antibacterial and antifungal chitosan and its derivativesCarbohydr Polym201716426828328325326
- KongMChenXGXingKParkHJAntimicrobial properties of chitosan and mode of action: a state of the art reviewInt J Food Microbiol2010144516320951455
- HayashiYOharaNGannoTIshizakiHYanagiguchiKChitosan containing gum chewing accelerates antibacterial effect with an increase in salivary secretionJ Dent20073587187417900783
- HayashiYOharaNGannoTChewing chitosan-containing gum effectively inhibits the growth of cariogenic bacteriaArch Oral Biol20075229029417112460
- TeimouriAMotevalli HaghiANateghpourMAntimalarial efficacy of low molecular weight chitosan against Plasmodium berghei infection in miceJ Vector Borne Dis20165331231628035107
- TavassoliMImaniATajikHMoradiMPourseyedSHNovel in vitro efficiency of chitosan biomolecule against Trichomonas gallinaeIran J Parasitol201279296
- YarahmadiMFakharMEbrahimzadehMAChabraARahimiesboeiBThe anti-giardial effectiveness of fungal and commercial chitosan against Giardia intestinalis cysts in vitroJ Parasit Dis201640758027065602
- PrietoMJBacigalupeDPardiniONanomolar cationic dendrimeric sulfadiazine as potential antitoxoplasmic agentInt J Pharmcol2006326160168
- AliMAfzalMVermaMMisra-BhattacharyaSAhmadFJDindaAKImproved antifilarial activity of ivermectin in chitosan–alginate nanoparticles against human lymphatic filarial parasite, Brugia malayiParasitol Res20131122933294323828187
- Danesh-BahreiniMAShokriJSamieiAKamali-SarvestaniEBarzegar-JalaliMSolimanMSNanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c miceInt J Nanomedicine2011683584221589651
- JiangSHuaELiangMLiuBXieGA novel immunosensor for detecting Toxoplasma gondii-specific IgM based on goldmag nanoparticles and grapheme sheetsColloids Surf B Biointerfaces201310148148623010058
- TripathySDasSChakrabortySPSahuSKPramanikPRoySSynthesis, characterization of chitosan-tripolyphosphate conjugated chloroquine nanoparticle and its in vivo anti-malarial efficacy against rodent parasite: a dose and duration dependent approachInt J Pharmacol2012434292305
- SaidDEElSamadLMGoharYMValidity of silver, chitosan and curcumin nanoparticles as anti-giardia agentsParasitol Res201211154555422392135
- FögerFNoonpakdeeWLoretzBInhibition of malarial topoi-somerase II in Plasmodium falciparum by antisense nanoparticlesInt J Pharm200631913914616713146
- KayserOA new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensionsRes Appl20012148385
- PujalsGSune-NegreJMPérezPIn vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantumParasitol Res20081021243124718278586
- RaafatDSahlHGChitosan and its antimicrobial potential – a critical literature surveyMicrob Biotechnol2009218620121261913
- SekiguchiSMiuraYKanekoHMolecular weight dependency of antimicrobial activity by chitosan oligomersNishinariKEFood Hydrocolloids: Structures, Properties and FunctionsNew YorkPlenum Press1994
- KumarABVVaradarajMCGowdaLRTharanathanRNCharacterization of chito-oligosaccharides prepared by chitosanolysis with the aid of papain and pronase, and their bactericidal action against Bacillus cereus and Escherichia coliBiochem J200539116717515932346
- ShinYMinKKimHKAntimicrobial finishing of polypropylene non-woven fabric by treatment with chitosanDomardARobertsGAFVarumKMAdvances in Chitin Science (II)Lyon, FranceJacques Andre Publisher1997771778
- El-TombaryAAIsmailKAAoulwafaOMOmarAMEEl-AzzouniMZEl-MansourySTNovel triazolo(4,3-a)quinazoline and bistriazolo(4,3-a: 4,3-c)quinazolines: synthesis and antitoxoplasmosis effectII Farmaco199954486495
- HammoudaNAEl-MansourySTEl-AzzouniMZToxoplasma gondii: scanning electron microscopic study before and after treatmentJ Trop Med199227783